Protective effects of Lactobacillus rhamnosus GG against human rotavirus-induced diarrhoea in a neonatal mouse model

Pathogens and Disease

Volumn 67, Issue 3, 2013, Pages 184-191

  Zhang, Zhen ^a   Xiang, Yun ^a   Li, Na ^b   Wang, Baoxiang ^a   Ai, Hongwu ^a   Wang, Xiaomei ^a   Huang, Laiqiang ^b   Zheng, Yi ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

Diarrhoea; Dosage dependent; Human rotavirus; Lactobacillus rhamnosus GG; timing dependent

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN A; LACTOBACILLUS RHAMNOSUS GG; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VACUOLE; COLONY FORMING UNIT; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DRUG MEGADOSE; FECES ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN ROTAVIRUS; INFECTION PREVENTION; INTESTINAL SECRETION; INTESTINE MUCOSA; JEJUNUM; LACTOBACILLUS RHAMNOSUS; MICROVILLUS; MOUSE; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ROTAVIRUS INFECTION; VIRUS SHEDDING;

ANIMALS; ANIMALS, NEWBORN; ANTIBIOSIS; BIOLOGICAL THERAPY; CYTOKINES; DIARRHEA; DISEASE MODELS, ANIMAL; FEMALE; GASTROENTERITIS; HUMANS; IMMUNOGLOBULIN A, SECRETORY; INTESTINAL MUCOSA; LACTOBACILLUS RHAMNOSUS; MICE; ROTAVIRUS INFECTIONS; TREATMENT OUTCOME;

EID: 84883780818     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1111/2049-632X.12030     Document Type: Article

References (38)

1. Boshuizen JA, Reimerink JH, Korteland AM, Ham VJ & Koopmans MP (2003) Changes in small intestinal homeostasis, morphology, and gene expression during RV infection of infantmice. J Virol 77: 13005-13016.
2. Costa-Ribeiro H, Ribeiro TC & Mattos AP (2003) Limitations of probiotic therapy in acute, severe dehydrating diarrhea. J Pediatr Gastroenterol Nutr 36: 112-115.
3. Cunningham-Rundles C (2001) Physiology of IgA and IgA deficiency. J Clin Immunol 21: 303-309.
4. Danan CG, Meslin JC, Lambre F, Charpilienne A & Serezat M (1998) Development of a heterologous model in germfree suckling rats for studies of RV diarrhea. J Virol 72: 9298-9302.
5. Donato KA, Gareau MG, Wang YJJ & Sherman PM (2010) Lactobacillus rhamnosus GG attenuates interferon-c and tumour necrosis factor-a-induced barrier dysfunction and pro-inflammatory signalling. Microbiology 156: 3288-3297.
6. Fang SB, Lee HC, Hu JJ, Hou SY, Liu HL & Fang HW (2009) Dosedependent effect of Lactobacillus rhamnosus on quantitative reduction of faecal rotavirus shedding in children. J Trop Pediatr 55: 297-301.
7. Feng NG, Jaimes MC, Lazarus NH, Monak D & Zhang CQ (2006) Redundant role of chemokines CCL25/TECK and CCL28/MEC in IgA+ plasmablast recruitment to the intestinal lamina propria after RV infection. J Immunol 176: 5749-5759.
8. Ferrie S & Daley M (2011) Lactobacillus GG as treatment for diarrhea during enteral feeding in critical illness: randomized controlled trial. J Parenter Enteral Nutr 35: 43-49.
9. Grandy G, Medina M, Soria R, Terán CG & Araya M (2010) Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infect Dis 10: 253.
10. Guandalini S, Pensabene L, Zikri MA et al. (2000) Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 30: 54-60.
11. Guarino A, Vecchio AL & Canani RB (2009) Probiotics as prevention and treatment for diarrhea. Curr Opin Gastroen 25: 18-23. Guerrero CA, Santana AY & Orlando A (2010) Mouse intestinal villi as a model system for studies of RV infection. J Virol Methods 168: 22-30.
12. Guerrero CA, Santana AY & Orlando A (2010) Mouse intestinal villi as a model system for studies of RV infection. J Virol Methods 168: 22-30.
13. Isolauri E (2004) The role of probiotics in paediatrics. Curr Paediatr 14: 104-109.
14. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P & Koivula T (1991) A human Lactobacillus strain (Lactobacillus Casei strain GG) promotes recovery from acute diarrhea in children. Pediatrics 88: 90-97.
15. Isolauri E, Joensuu J, Suomalainen H, Luomala M & Vesikari T (1995) Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine Lactobacillus casei GG. Vaccine 13: 310-312.
16. Kaila M, Isolauri E, Saxelin M, Arvilommi H & Vesikari T (1995) Viable versus inactivated lactobacillus strain GG in acute RV diarrhea. Arch Dis Child 72: 51-53.
17. Knipping K, McNeal MM, Crienen A, Amerongen G, Garssen J & Land BV (2011) A gastrointestinal rotavirus infection mouse model for immune modulation studies. J Virol 8: 109.
18. Majerowicz S, Kubelka CF, Stephens P & Barth OM (1994) Ultrastructural study on experimental infection of RV in a murine heterologous model. Mem Inst Oswaldo Cruz 89: 395-402.
19. Mastretta E, Longo P, Laccisaglia A, Balbo L, Russo R, Mazzaccara A & Gianino P (2002) Effect of Lactobacillus GG and breastfeeding in the prevention of RV nosocomial infection. J Pediatr Gastroenterol Nutr 35: 527-531.
20. Mattar AF, Drongowski RA, Coran AG & Harmon CM (2001) Effect of probiotics on enterocyte bacterial translocation in vitro. Pediatr Surg Int 17: 265-268.
21. O'Ryan M, Lucero Y, O'Ryan-Soriano MA & Ashkenazi S (2010) An update on management of severe acute infectious gastroenteritis in children. Expert Rev Anti Infect Ther 8: 671-682.
22. Ozuah PO, Avner JR & Stein RE (2002) Oral rehydration, emergency physicians, and practice parameters: a national survey. Pediatrics 109: 259-261.
23. Pant AR, Graham SM & Allen SJ (1996) Lactobacillus GG and acute diarrhoea in young children in the tropics. J Trop Pediatr 42: 162-165.
24. Pant N, Marcotte H, Brüssow H, Svensson L & Hammarstrom L (2007) Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies. BMC Microbiol 7: 86.
25. Petschow BW, Figueroa R, Harris CL, Beck LB, Ziegler E & Goldin B (2005) Effects of feeding an infant formula containing Lactobacillus GG on the colonization of the intestine: a dose-response study in healthy infants. J Clin Gastroenterol 39: 786-790.
26. Ritchie BK, Brewster DR, Tran CD, Davidson GP & McNeil Y (2010) Efficacy of Lactobacillus GG in aboriginal children with acute diarrhea disease: a randomized clinical trial. J Pediatr Gastroenterol Nutr 50: 619-624.
27. Sugata K, Taniguchi K, Yui A, Miyake F & Suqa S (2008) Analysis of rotavirus antigenemia and extra-intestinal manifestation in children with rotavirus gastroenteritis. Pediatrics 122: 329-397.
28. Szajevska H, Kotowska M, Mrukovicz JZ, Armanska M & Mikolajezyk W (2001) Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 138: 361-365.
29. Szajewska H & Mrukowicz JZ (2005) Use of probiotics in children with acute diarrhea. Paediatr Drugs 7: 111-122.
30. Szajewska H, Skorka A, Ruszczynski M & Gieruszczak-Bialek D (2007) Metaanalysis: Lactobacillus GG for treating acute diarrhea in children. Aliment Pharmacol Ther 25: 871-881.
31. Takahashi K, Matsuda M, Ohashi K, Taniguchi K, Nakagomi O, Okutani K, Sato N, Abe Y & Shigeta S (2001) Analysis of antirotavirus activity of extract from Stevia rebaudiana. Antivir Res 49: 15-24.
32. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J & Parashar UD (2012) 2008 estimate of worldwide RV-associated mortality in children younger than 5 years before the introduction of universal RV vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 12: 136-141.
33. Van Niel C, Feudtner C & Garrison MM (2002) Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 109: 678-684.
34. Warfield KL, Blutt SE, Crawford SE, Kang G & Conner ME (2006) Rotavirus infection enhances lipopolysaccharide-induced intussusception in a mouse model. J Virol 80: 12377-12386.
35. Wen K, Li GH, Bui T, Liu FN, Li YR, Kocher J, Lin L, Yang XD & Yuan LJ (2012) High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs. Vaccine 30: 1198-1207.
36. Weninger W & Andrian UH (2003) Chemokinetic regulation of naïve T cell traffic in health and disease. Semin Immunol 15: 257-270.
37. Williams MB, Rosé JR, Rott LS, Franco MA & Greenberg HB (1998) The memory B cell subset responsible for the secretory IgA response and protective humoral immunity to RV expresses the intestinal homing receptor, alpha4 beta7. J Immunol 161: 4227- 4235.
38. Zhang LY, Li N, Caicedo R & Neu J (2005) Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factoralpha- induced interleukin-8 production in Caco-2 cells. J Nutr 135: 1752-1756.